Determination of the anticancer agent CI-980 in plasma by achiral liquid chromatography on a Pirkle-type stationary phase
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 693 (2) , 493-497
- https://doi.org/10.1016/s0378-4347(97)00077-7
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.Journal of Clinical Oncology, 1995
- High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1995